ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Magnetic resonance imaging (MRI)"

  • Abstract Number: 1521 • 2019 ACR/ARP Annual Meeting

    Ixekizumab Is Effective in the Treatment of Radiographic Axial Spondyloarthritis Regardless of the Level of C-Reactive Protein or Magnetic Resonance Imaging Scores

    Walter P. Maksymowych1, Gaia Gallo 2, Rebecca Bolce 3, Fangyi Zhao 2, Vladimir Geneus 3, Mikkel Østergaard 4, Kurisu Tada 5, Atul Deodhar 6 and Lianne Gensler 7, 1University of Alberta/CARE ARTHRITIS, Edmonton, AB, Canada, 2Eli Lilly and Company, Indianapolis, IN, 3Eli Lilly and Company, Indianapolis, 4Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark, 5Juntendo University School of Medicine, Tokyo, Japan, 6Oregon Health & Science University, Portland, OR, 7University San Francisco California, San Francisco, CA

    Background/Purpose: IL-17 plays an important role in the pathogenesis of radiographic axial spondyloarthritis (r-axSpA). Elevated CRP levels in serum predict response to TNF inhibitors (TNFi).1-4…
  • Abstract Number: 591 • 2019 ACR/ARP Annual Meeting

    Longitudinal Assessment of MRI of the Sacroiliac Joints in the ASAS Classification Cohort: Evolution of Diagnostic Features and Predictive Utility for Axial Spondyloarthritis

    Walter P. Maksymowych1, Xenofon Baraliakos 2, Manouk de Hooge 3, Iris Eshed 4, Susanne Juhl Pedersen 5, Ulrich Weber 6, Joachim Sieper 7, Stephanie Wichuk 8, Denis Poddubnyy 9, Martin Rudwaleit 10, Désirée van der Heijde 11, Robert B.M. Landewé 12, Joel Paschke 13, Robert Lambert 8 and Mikkel Østergaard 14, 1University of Alberta/CARE ARTHRITIS, Edmonton, AB, Canada, 2Rheumatology Department, Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 3Ghent University Hospital, Ghent, Belgium, 4Sheba Medical Center, Tel Aviv, Israel, 5Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Hovedstaden, Denmark, 6Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sonderborg, Denmark, 7Charité Universitätsmedizin Berlin, Germany, Berlin, Germany, 8University of Alberta, Edmonton, Canada, 9Charité - Universitätsmedizin Berlin and German Rheumatism Research Centre, Berlin, Germany, Berlin, Germany, 10Klinikum Bielefeld, Charité Berlin, Gent University, Bielefeld, Germany, 11Leiden University Medical Center, Leiden, Netherlands, 12Amsterdam University Medical Center, Amsterdam, Netherlands, 13CARE Arthritis, Edmonton, Canada, 14Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark

    Background/Purpose: Follow up of the ASAS Classification Cohort (CC) indicated a high positive predictive value for the ASAS classification criteria derived from baseline patient and…
  • Abstract Number: 1738 • 2019 ACR/ARP Annual Meeting

    Tracking Whole-Brain Volumetric Trends in Childhood-onset Systemic Lupus Erythematosus Patients in the Clinical Setting by Magnetic Resonance Imaging

    Hermine Brunner1, Arjun Mathur 2, William O'Brien 3 and Mark DiFrancesco 3, 1Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: The course of childhood-onset Systemic Lupus Erythematosus (cSLE) commonly includes neurocognitive dysfunction, a manifestation with poor prognosis. It has been challenging to diagnose and…
  • Abstract Number: L05 • 2018 ACR/ARHP Annual Meeting

    Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Reversible Abnormalities of Vascular Function on Cardiac MRI with RA Therapy with Preliminary Suggestion of Greater Improvement with Anti-TNF Compared to MTX/Conventional Therapy – a First, RCT Derived Longitudinal Study

    Maya H. Buch1, Bara Erhayiem2, Graham Fent2, Paul Baxter3, Elizabeth M.A. Hensor4, Adam McDiarmid2, Peter Swoboda5, Ananth Kidambi2, David Ripley2, Pankaj Garg2, Sarah Horton4, Raluca Bianca Dumitru4, Kamran Naraghi4, John Greenwood6, Paul Emery7, Sue Pavitt8 and Sven Plein2, 1Leeds Institute of Rheumatic & Musculosekeltal Medicine, University of Leeds & NIHR Biomedical Research Centre, Leeds, United Kingdom, 2Multidisciplinary Cardiovascular Research Centre, Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 3Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 4Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Leeds Institute of Cardiovascular And Metabolic Medicine, University of Leeds, Leeds, United Kingdom, 6Leeds Institute of Cardiovascular And Metabolic Medicinee, University of Leeds, Leeds, United Kingdom, 7University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, 8Leeds School of Dentistry, University of Leeds, Leeds, United Kingdom

    Background/Purpose: We previously reported abnormal cardiac MRI (CMR)-determined aortic stiffness in patients with early, treatment-naive RA1,2. We now report on whether this vascular stiffness is…
  • Abstract Number: 319 • 2018 ACR/ARHP Annual Meeting

    Patterns of Muscle Oedema, Atrophy and Fatty Replacement in the Idiopathic Inflammatory Myopathies: A Single-Centre Retrospective Review of Magnetic Resonance Imaging Data

    Jessica Day1,2, Nicholas Bajic3, Sheridan Gentili4, Sandy Patel5 and Vidya Limaye6, 1Rheumatology, Royal Adelaide Hospital, Adelaide, Australia, 2Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia, 3Dr Jones and Partners St Andrew's and Calvary Wakefield Hospitals, Adeliad, Australia, 4University of South Australia, Adelaide, Australia, 5Radiology, Royal Adelaide Hospital, Adelaide, Australia, 6Rheumatology, The Royal Adelaide Hospital, Adelaide, Australia

    Background/Purpose: Magnetic resonance imaging (MRI) has been used as a non-invasive tool to aid diagnosis and monitor disease activity in the idiopathic inflammatory myopathies (IIMs).…
  • Abstract Number: 390 • 2018 ACR/ARHP Annual Meeting

    Severe Axial and Pelvifemoral Muscle Damage in Immune-Mediated Necrotizing Myopathy Evaluated By Whole-Body MRI

    Océane Landon-Cardinal1, Cedi Koumako2, Giulia Hardouin3, Benjamin Granger3, Harmen Reyngoudt2, Jean-Marc Boisserie2, Aude Rigolet1, Baptiste Hervier1, Nicolas Champtiaux1, Perrine Guillaume1, Mathieu Vautier1, Pierre Carlier2, Olivier Benveniste1 and Yves Allenbach1, 1Department of Internal Medicine and Clinical Immunology and Inflammation-Immunopathology-Biotherapy Department (I2B), Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, East Paris Neuromuscular Diseases Reference Center, Paris, France, 2Laboratoire de RMN AIM & CEA, Centre d'Explorations Fonctionnelles, Institut de Myologie, Paris, France, 3Département de Biostatistiques, Santé Publique et Information Médicale, Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France

    Background/Purpose: Immune-mediated necrotizing myopathies (IMNM) are a severe condition with early muscle damage attested by MRI of thigh muscles. Presence of damage in the other…
  • Abstract Number: 420 • 2018 ACR/ARHP Annual Meeting

    Accelerated Knee Osteoarthritis Is Characterized By Destabilizing Meniscal Tears and Pre-Radiographic Structural Disease Burden

    Jeffrey B. Driban1, Julie Davis2, Bing Lu3, Lori Lyn Price4,5, Robert J. Ward6, James MacKay7, Charles B. Eaton8, Grace H. Lo9, Mary Barbe10, Ming Zhang11, Jincheng Pang12, Alina Stout13, Matthew Harkey13 and Timothy E. McAlindon14, 1Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA, 2Rheumatology, Tufts Medical Center, BOSTON, MA, 3Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 4Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Radiology, Tufts Medical Center, Boston, MA, 7Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 8Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 9Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 10Temple University School of Medicine, Philadelphia, PA, 11Tufts Medical Center, Boston, MA, 12Electrical Engineering, Tufts University, Medford, MA, 13Rheumatology, Tufts Medical Center, Boston, MA, 14Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: A subset of adults who develop knee osteoarthritis (KOA) quickly progress from no radiographic disease to advanced-stage disease often in ≤12 months. Adults with…
  • Abstract Number: 431 • 2018 ACR/ARHP Annual Meeting

    Early Pre-Radiographic Structural Pathology Precedes the Onset of Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    Matthew Harkey1, Julie Davis2, Bing Lu3, Lori Lyn Price4,5, Robert J. Ward6, James MacKay7, Charles B. Eaton8, Grace H. Lo9, Mary Barbe10, Ming Zhang11, Jincheng Pang12, Alina Stout1, Timothy E. McAlindon13 and Jeffrey B. Driban14, 1Rheumatology, Tufts Medical Center, Boston, MA, 2Rheumatology, Tufts Medical Center, BOSTON, MA, 3Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 4Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Radiology, Tufts Medical Center, Boston, MA, 7Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 8Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 9Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 10Temple University School of Medicine, Philadelphia, PA, 11Tufts Medical Center, Boston, MA, 12Electrical Engineering, Tufts University, Medford, MA, 13Division of Rheumatology, Tufts Medical Center, Boston, MA, 14Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Individuals that develop accelerated knee osteoarthritis (AKOA) have more frequent knee pain, decreased physical function, and are more likely to receive a knee replacement…
  • Abstract Number: 562 • 2018 ACR/ARHP Annual Meeting

    Low Inflammation on Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis That Achieved Sustained Clinical Remission on Adalimumab

    Paul Emery1, Gerd R. Burmester2, Esperanza Naredo3, Ivan Lagunes Galindo4, Ying Zhang5, Xin Wang5, Maja Hojnik6 and Philip G. Conaghan7, 1University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, 2Charité-University Medicine Berlin, Free University and Humboldt University Berlin, Berlin, Germany, 3Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain, 4AbbVie Inc., North Chicago, IL, 5AbbVie, North Chicago, IL, 6AbbVie, Ljubljana, Slovenia, 7University of Leeds, Leeds, United Kingdom

    Background/Purpose: ACR and EULAR recommend bDMARD tapering in patients (pts) with rheumatoid arthritis (RA) who achieved stable clinical remission. Yet, there are limited systematically collected…
  • Abstract Number: 863 • 2018 ACR/ARHP Annual Meeting

    Combining Cardiac Magnetic Resonance and Right Heart Catheterization to Evaluate Right Ventricular Function for the Prognosis Prediction in Patients with Connective Tissue Diseases and Pulmonary Hypertension

    Nobuya Abe1, Masaru Kato2, Hiroyuki Nakamura2, Atsushi Noguchi2, Yuichiro Fujieda2, Kenji Oku2, Toshiyuki Bohgaki2, Olga Amengual2, Shinsuke Yasuda2 and Tatsuya Atsumi2, 1Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 2Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    Background/Purpose: Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH), particularly PAH associated with systemic sclerosis (SSc-PAH), has a poor prognosis compared with other PAH.…
  • Abstract Number: 952 • 2018 ACR/ARHP Annual Meeting

    Effusion-Synovitis and Infrapatellar Fat Pad Edema Differentiate Accelerated Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    Julie Davis1, Robert J. Ward2, James MacKay3, Bing Lu4, Lori Lyn Price5,6, Timothy E. McAlindon7, Charles B. Eaton8, Mary Barbe9, Grace H. Lo10, Matthew Harkey1 and Jeffrey B. Driban11, 1Rheumatology, Tufts Medical Center, Boston, MA, 2Radiology, Tufts Medical Center, Boston, MA, 3Radiology, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 4Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 5Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 6Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 7Division of Rheumatology, Tufts Medical Center, Boston, MA, 8Family Medicine and Community Health( Epidemiology), Alpert Medical School of Brown University, Pawtucket, RI, 9Temple University School of Medicine, Philadelphia, PA, 10Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 11Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Accelerated knee osteoarthritis (AKOA) is a unique endotype of knee osteoarthritis (KOA) that is characterized by a sudden onset of advance-stage disease and greater…
  • Abstract Number: 954 • 2018 ACR/ARHP Annual Meeting

    A New Way to Think about Composite Magnetic Resonance Imaging Scores to Measure Osteoarthritis Severity and Progression

    Lori Lyn Price1,2, Jeffrey B. Driban3, Grace H. Lo4, Ming Zhang5, Michael P. LaValley6 and Timothy E. McAlindon7, 1Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 2Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 3Medicine, Division of Rheumatology, Tufts Medical Center, Boston, MA, 4Michael E. DeBakey Veterans Affairs Medical Center / Baylor College of Medicine, Houston, TX, 5Tufts Medical Center, Boston, MA, 6Biostatistics, Boston University School of Public Health, Boston, MA, 7Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: For some rheumatologic diseases (e.g. lupus), separate scores evaluate cumulative damage and disease activity.  No such strategy exists for osteoarthritis (OA).  The prevailing approach…
  • Abstract Number: 1646 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Spondyloarthritis in Patients with Anterior Uveitis

    Kristyna Bubova1,2, Monika Gregová1,2, Katerina Zegzulkova1,2, Karel Pavelka1,2, Jarmila Heissigerova3,4 and Ladislav Šenolt2,5, 1Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 3Department of Ophthalmology, First Faculty of Medicine, Charles University, Prague Czech Republic, Prague, Czech Republic, 4Department of Ophthalmology, General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic, 5First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Anterior uveitis (AU) is a common extraarticular manifestation in spondyloarthritis (SpA). The disease can precede the typical axial and peripheral features. Additionally, some studies…
  • Abstract Number: 2196 • 2018 ACR/ARHP Annual Meeting

    Kinetics of Tissue-Specific Distribution of 18f-Fluorodeoxyglucose in Positron Emission Tomography in Large Vessel Vasculitis

    Joel S. Rosenblum1, Kaitlin Quinn2, Mark A. Ahlman3 and Peter C. Grayson4, 1NIAMS, National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, 2Systemic Autoimmunity Branch, NIAMS, Bethesda, MD, 3Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, 4National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD

    Background/Purpose: 18F-fluorodeoxyglucose (FDG) PET may be used to quantify vascular inflammation in large-vessel vasculitis (LVV).  Quantitative analysis of arterial FDG uptake has not been standardized. Delayed…
  • Abstract Number: 306 • 2018 ACR/ARHP Annual Meeting

    The Role of Inflammation in the Evolution of MRI Erosions in the Feet of Patients with Early RA

    Hanyan Zou1, Karen A. Beattie2, Saara Totterman3, George Ioannidis1 and Maggie Larche2,4, 1McMaster University, Hamilton, ON, Canada, 2Medicine, McMaster University, Hamilton, ON, Canada, 3Qmetrics Technologies, Pittsford, NY, 4St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: Patients with aggressive RA develop early structural damage. As persistent inflammation is associated with bone erosions, assessing inflammatory activity may be key in treatment…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology